V. R. M, G. Gnk, B. B, R. Jagadeesan, and P. K. M R, “Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration: Risk assessment of CGT and PC Exclusivity drugs”, AMM, vol. 68, no. 1, Mar. 2022.